Advances in imaging techniques have allowed researchers to better understand these mechanisms, paving the way for potential clinical ... manifestations associated with systemic lupus erythematosus.

Systemic lupus erythematosus is a multisystem autoimmune disease with wide-ranging pleuropulmonary manifestations. Acute lupus pneumonitis is one of its uncommon complications. We report a 36-year-old ...

Systemic lupus erythematosus (SLE) often presents with neuropsychiatric (NP) involvement, including cognitive impairment and depression. Past magnetic resonance imaging (MRI) research in SLE patients ...

In this difficult clinical situation ... rituximab? SLE: Systemic lupus erythematosus. Symptoms of systemic lupus erythematosus (SLE) must be brought under control to avert immediate consequences ...

SLE: Systemic lupus erythematosus. Symptoms of systemic lupus erythematosus (SLE) must be brought under control to avert immediate consequences and afford the patient a better quality of life.

EULAR/ACR SLE classification criteria were not linked to mortality or hospitalization, a developed ominosity model adequately predicted mortality.

uhn.ca Objective To develop new classification criteria for systemic lupus erythematosus (SLE) jointly supported by the European ... and regardless of their specific clinical or immunological ...

Systemic lupus erythematosus (SLE ... serious condition that occurs in 5-10% of SLE patients and can present with symptoms ranging from unexplained tachycardia to severe heart failure.

163.com Pulmonary arterial hypertension (PAH) is a severe complication of systemic lupus erythematosus (SLE), and SLE-PAH is the most common ... pulmonary thrombosis and lung diseases were excluded.4 ...

Imvotamab is under clinical development by IGM Biosciences and currently in Phase I for Systemic Lupus Erythematosus. According to GlobalData, Phase I drugs for Systemic Lupus Erythematosus have a 73% ...

RG-6382 is under clinical development by F. Hoffmann-La Roche and currently in Phase I for Systemic Lupus Erythematosus. According to GlobalData, Phase I drugs for Systemic Lupus Erythematosus have a ...

Neuropsychiatric SLE (NPSLE) encompasses neurological and psychiatric symptoms in patients with SLE ... Lumbar puncture was indicated in patients in whom clinical suspicion of neuropsychiatric lupus ...